INTRODUCTION
An acute and fatal infectious disease affecting rabbits was reported in 48 rabbit colonies in eastern Slovakia in October 1987 (11) . By the end of 1988, the disease had spread to several rabbit colonies in the middle and western areas of the Czech and Slovak Federal Republic (CSFR). Owing to the similarity of clinical signs, necropsy, results of experimental transmission and electron microscopic demonstration of calicivirus-like particles in various organs of experimentally-and naturally-infected rabbits, the authors suggested that the disease was identical to that described earlier in the People's Republic of China (1, 3, 5, 8, 15, 16) .
Preventive measures and haemagglutination (HA) and electron microscopy (EM) were used in co-operation with the State Veterinary Administration. An inactivated vaccine and further methods for virus and antibody demonstration were developed at the Veterinary Research Institute in Brno. Studies of the properties of the causal agent were also initiated. These activities resulted in the implementation of the diagnostic and control measures in the CSFR described in this paper.
EPIDEMIOLOGY
Viral haemorrhagic disease (VHD) of rabbits, an acute and fatal infectious disease which was reported in eastern Slovakia in October 1987 (11) had, by the end of 1988, spread throughout the CSFR. The clinical course of infection was very rapid, with death occurring within several hours to two days after the onset of clinical signs. These included listlessness, anorexia, epistaxis and, most frequently, death in opisthotonus. Occasionally, however, clinical signs were absent, or very mild. Post-mortem examinations revealed haemorrhagic lung oedema and typical haemorrhages in the liver, spleen, heart, kidneys and respiratory tract. Most authors report an incubation period of 48-72 h. In the experiments conducted by the authors, some rabbits died within 24 h after experimental infection. None of the hares, mice, hamsters, chinchillas and colostrum-deprived piglets showed any clinical signs within one month after inoculation of VHD virus (VHDV) suspension (13) .
Analysis of the spread of VHD and its clinical course in the CSFR revealed morbidity and mortality of 80-100%. Only small rabbit-breeding colonies, involving approximately 30 million animals in summer and autumn, were affected. Large rabbit farms, representing a negligible fraction of the rabbit population in the CSFR, remained free from clinical infection. Although the spread of the infection was very rapid, territorial continuity between foci did not always exist. In such cases, the infection may have spread by the transport of infected animals or objects. A rather interesting course of the disease was occasionally observed in localities where no previous outbreak had been reported or vaccination performed. Some breeders suffered a total loss of their colonies, while others in the immediate neighbourhood were unaffected, suffering either sporadic deaths (interpreted as a result of nutritional disorders or of parasitic infection) or no deaths at all. The authors assume that these differences can be explained by the presence of "naturally-acquired" antibodies to VHDV in some colonies.
The presence of such "naturally-acquired" antibodies was demonstrated by enzyme-linked immunosorbent assay (ELISA) in 19.4% of the 1,461 rabbit blood samples collected in 43 clinically infection-free localities. Doubtful values were found in 19.7% of samples and 60.9% were free of antibodies (Table I) . The decisive effects demonstrated in a series of experiments (10, 13) . Death rates after experimental infection were 4.3%, 22.2% and 97.3% in the groups of rabbits with high, low and zero antibody levels, respectively (Table II) . The seasonal character of rabbit breeding, common to all small colonies, as well as the highly contagious and tenacious nature of VHDV (Table III) and the presence of "naturally-acquired" antibodies all determine the epidemiological pattern of VHD. The rabbit population during the first half of each year consists of animals younger than two months, which are known to be resistant to VHD, and parent animals, a high percentage of which are serologically positive or have post-vaccination antibodies. In the second half of the year, however, animals older than two months -and therefore highly susceptible to infection -predominate in the population. Under such conditions, an outbreak in a colony of unvaccinated rabbits results in losses as high as 80-100%. The results, summarised in Table IV, demonstrate that the resistance of young rabbits to experimental infection is not mediated by passively acquired (maternal) antibodies, and that the resistance decreases with advancing age. a) The resistance of young dams (see b) rabbits does not appear to be linked to the antibodies which exist and protect their
b) All dams survived after experimental infection
The source of infection was also investigated by the authors. Results of both ELISA and Western blot analysis, using VHD-positive sera and the Chinese reference serum, have confirmed the identity and causal agent of the disease as reported from the People's Republic of China and from Europe (10, 14) . Far more important, however, is the fact that identical positive results were obtained by both methods when rabbit sera, collected in the CSFR from 1975 to 1987 (i.e. before the first outbreaks in the People's Republic of China and Europe), were examined. A set of 42 sera of rabbits was used to obtain hyperimmune sera to various viral antigens and to bovine and porcine immunoglobulins. The sera, stored in a freeze-dried state at -20°C, retained high specificity. "Naturally-acquired" antibodies to VHDV were demonstrated in 32 (76.2%) samples. The high percentage of positive sera may have resulted from the increased infection hazard in laboratory rabbits due to such factors as longer lifespans (over one year), frequent translocations and a continuous supply of rabbits from various sources. The specificity of the reactions was confirmed by comparisons with convalescent and reference sera. All rabbit sera positive in ELISA reacted identically with the major structural proteins of VHDV in Western blot analysis. These results support the assumption that rabbit colonies had been infected with a virus many years before the first outbreaks of VHD were reported from the People's Republic of China (1984) and Europe (1987) . This virus, sharing the major structural proteins with VHDV, had low virulence and did not cause serious problems in rabbit colonies (10) (Table V) . 
DIAGNOSIS OF VHD
If losses are recorded, the use of rapid and sensitive diagnostic techniques is essential before decisions can be made on the control or prevention of the disease. Equally important is the determination of antibodies to VHDV in the blood of convalescent rabbits, in vaccine potency checks, in screening investigations and in the selection of animals for experiments.
Demonstration of VHD virus

Electron microscopy
The virus was demonstrated in the liver of rabbits by the negative staining method (2, 7, 12, 14) . Two to three drops of distilled water were added to small pieces of the examined tissue (approximately 1 mm); a formwar-carbon coated grid was then placed on the surface of the fluid and left there for approximately 20 seconds. After the mesh had been lifted and the remnants of the fluid removed, the preparation was stained with a 2% aqueous molybdate solution and immediately examined by electron microscope. This method was used to examine more than 650 rabbits.
Negative staining, immuno-electron microscopy (IEM) and the protein A-gold IEM were used for detailed studies. VHD virus was found to have a calicivirus-like structure and a diameter of 31.5-33.0 nm (Fig. 1) . In the People's Republic of China, the antigenic relationship between the VHD virus strain under investigation and the causal agent of VHD was demonstrated by IEM (14) . 
Haemagglutination test
Haemagglutination of human group-O erythrocytes by VHDV was used for virus demonstration in organ homogenates, prepared from suspected animals. High titres (10.2 8 " 12 ) were found in positive samples; low titres, which may result from certain bacterial infections (e.g., Pasteurella spp.), must be interpreted carefully. It has been reported that empty virus particles and virus-positive samples, altered by advanced autolysis, lack haemagglutinating activity (4, 6). The authors, in co-operation with veterinary investigation service laboratories, have confirmed these reports. VHDV was demonstrated by EM in many samples which were negative in the HA test. Further experiments are necessary to determine the specificity of the test.
Direct immunoperoxidase and immunofluorescence techniques
The immunoglobulin fraction of hyperimmune rabbit anti-VHDV sera, conjugated with fluorescein isothiocyanate (FITC) or peroxidase, was used successfully to demonstrate VHDV in cryostat sections and smears. The FITC-conjugate is available commercially and is currently used in local veterinary investigation service laboratories.
Indirect immunoperoxidase and immunofluorescence techniques using monoclonal antibodies
Hybridomas, producing monoclonal antibodies (MAbs) which react specifically with the dominant 61 kDa and another structural protein (38 kDa) of VHDV, were prepared for the indirect immunoperoxidase and immunofluorescence tests (9) . The specificity of the MAbs was confirmed by ELISA; no cross reactions with the feline calicivirus were observed. MAbs were used in both tests to demonstrate VHDV. The virus was demonstrated in cryostat sections, impressions and smears prepared from lung, spleen, kidney and liver samples collected from dead rabbits. Examinations of liver smears by the immunoperoxidase technique revealed the presence of VHDV in 50-90% of the cells; in freshly infected liver cells, VHDV was present in the cytoplasma only (Fig. 2) . All control incubations of positive and negative samples with normal mouse serum yielded negative results. The specificity of both techniques, for which diagnostic kits are now available commercially, was fully confirmed by EM examinations.
FIG. 2
Indirect immunoperoxidase demonstration of VHD virus in a liver tissue smear of an infected rabbit using monoclonal antibody (9) VHD virus is visible in the cytoplasm of freshly infected cells as a ring of dense granules -non-infected cells are pale
Demonstration of antibodies to VHDV
Haemagglutination inhibition test
The haemagglutination inhibition (HI) method has several disadvantages. Apart from low sensitivity, the HI test requires a continuous supply of human group-O erythrocytes for routine examinations, and nonspecific reactions are frequently observed in animals infected with Pasteurella spp.
Immunodiffusion test
Antibodies to VHDV in vaccinated, challenged or convalescent rabbits can be demonstrated by Ouchterlony's method of bi-directional immunodiffusion in 1% agar gel. This method, however, is time-consuming (24-48 h) and has low sensitivity. Positive sera form precipitation lines in dilutions from 1:2 to 1:16.
ELISA
The ELISA sandwich technique, using microtitre plates which had been pre-coated with purified VHDV, was performed. The presence of VHDV antibodies was demonstrated by the peroxidase-antibody to rabbit IgG conjugate. The method is highly sensitive and, among other advantages, it allows the susceptibility of rabbits to VHDV infection (Table II) and the immunity level in vaccine potency tests to be determined reliably. Antibody titres in convalescent animals range between 1:20000 and 1:80000 and reach 1:400,000 in hyperimmunised rabbits. ELISA was used successfully for the evaluation of hybridomas producing MAbs to VHDV if the antibody to rabbit IgG was replaced in the conjugate by the antibody to mouse IgG (9).
Western blot
The specificity of antibodies present in examined sera can be determined with high precision after separating the VHDV antigens in Polyacrylamide gel and then transferring them onto nitrocellulose membrane. This is a sophisticated method and is not suitable for routine use.
PROTECTIVE MEASURES General
After receiving a report from the diagnostic laboratory concerning clinical and epidemiological observations, pathological examinations and demonstration of VHDV, the district veterinary officer issued the following instructions:
-define the infection focus (locality, farm) where diseased or suspected animals, or another source of infection, were detected; -kill all diseased and suspected animals and destroy the carcasses carefully by incineration, or disinfect the carcasses and bury them at least 40 cm below ground; -disinfect animal houses, utensils and the environment; -forbid any transport of live animals or skins; -establish a protective zone around the focus in reference to the epidemiological pattern and geographic conditions; -vaccinate all rabbits in the protective zone and forbid any movement or purchase of rabbits or rabbit skins, and vaccinate against myxomatosis before the infection is eradicated.
VHD may be declared eradicated if no new case occurs within the focus and the protective zone during an observation period of 28 days, and after final disinfection, disinfestation and rodent control have been performed. Rabbit skins processed in the protective zone during the outbreak must be disinfected and may be transported only after VHD has been eradicated.
Specific protective measures
Owing to the short incubation period and the rapid course of the disease in affected animals, therapy of VHD is not feasible. Vaccination is the most effective measure to protect rabbit colonies against VHD. An inactivated vaccine, adsorbed on aluminium hydroxide, was developed and successfully tested in the Czech Republic in 1988 (13); serial production was subsequently launched the same year. To date, approximately 3.5 million doses have been supplied. One ml of the vaccine is administered subcutaneously to rabbits older than six weeks. Immunity develops from the fifth day post vaccination (p.v.) and rabbits are fully protected against challenge with 10 6 -5 LD 50 of VHDV after three weeks (Tables VI and VII) . A single vaccination provides immunity lasting at least six months. Vaccine potency is checked by serological examination (antibody determination by ELISA) and by challenge; only rabbits free from "naturally-acquired" antibodies to VHDV are selected for observation. The results of potency tests demonstrate the onset of detectable antibody formation on the fifth day p.v. (Table VI ) and the protection of vaccinated rabbits against challenge (Table VII) . These results have been confirmed by repeated laboratory controls and field observations. 
